Macro: Sandcastle economics
Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.
Summary: Equities saw further gains amid another drop in long-end Treasury yields despite a hot PPI as Fed’s Waller joined the less hawkish camp. US CPI out today will be the next big focus. Oil slid over 2% as evidence of Iran’s involvement in Israel conflict continued to lack, but Gold rose to fresh MTD highs. Dollar held steady with DXY below 106, but yen seems unmoved by the slide in yields.
The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events.
US Equities: The major US equity indices climbed for a fourth straight day with S&P 500 up 0.4% and NASDAQ 100 up 0.7% as Treasury yields continued to slide despite hot PPI. Kidney dialysis and related names (DVA, BAX, FMS) were heavily sold after Novo Nordisk (NVO) announced it would end a diabetes drug trial early after interim analysis for the treatment Ozempic showed success in preventing kidney failure. Eli Lilly posted fresh 1-year highs. Energy sector was the biggest loser in the S&P 500 amid the drop in oil prices, and Chevron was down 5.4% on headwinds in Israel and Australia, and Exxon down ~4% after its merger deal with Pioneer. Birkenstock IPO disappointed, falling 12% at its debut.
Fixed income: Treasuries saw a flattening as haven-demand due to the Israel conflict continued and Fed speaker Waller also beat a less hawkish drum like some of his peers recently. 2-year yields dropped to 4.95% earlier but ended the day 1bp higher on hot PPI while 10-year yields were down over 9bps. The USD 35bln 10yr note reopening saw weak demand, adding to the poor 3yr auction on Tuesday.
China/HK Equities: The Hang Seng Index continued to rally, adding over 1% on a Bloomberg story suggesting China is considering higher fiscal spending financed by an additional RMB 1 trillion central government debts. The news can help sentiment but its impact is likely to fade. Even if it materializes, which we doubt, investors may not think that is enough. On the other hand, the deeply negative sentiment reflecting in a flurry of earnings downward revisions and underweight positions may be a good breeding ground for a tradable rally. Soon, the market will also have its eyes on the 3rd Plenary Session of the 20th Central Committee.
FX: The dollar was steady with the DXY index below 106 as market paid little heed to hot PPI report. GBPUSD continues to test 1.23 for a firmer break while EURUSD is having trouble going above 1.0620 for now with gas prices and Italian yields remaining in focus, as most ECB speakers continue to hint at extending the rate pause. Lack of follow-on on China stimulus saw AUDUSD plunge below 0.64 although it rose just above the big figure later, while NZDUSD slid from 0.6050 buy is still holding on to the 0.60 support. USDJPY still close to 149 despite further slide in long-end yields. EURCHF stays below 0.96 on safe haven demand.
Commodities: Energy markets took a breather after the recent run higher following escalation in geopolitical tensions over the weekend. Oil prices dropped by over 2% as a NY Times article said ‘early intelligence shows Hamas attack surprised Iranian leaders U.S. says’, reducing the risk of Iran being dragged in the conflict. EIA STEO cut world oil demand growth forecasts for 2023 and 2024, and monthly oil market reports by OPEC and IEA out today. The surge in gas prices in Europe also stalled. Gold took another leg up, rising to over $1870 as long-end yields slid further.
Macro:
Macro events: ECB Minutes, UK GDP (Aug) exp 0.2% vs. -0.5% prior, US CPI (Sep) exp 3.6% YoY vs. 3.7% prior – read Saxo’s full preview here. US jobless claims exp. 210k vs 207k prior.
In the news:
For all macro, earnings, and dividend events check Saxo’s calendar.
For a global look at markets – go to Inspiration.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)